VanEck Associates’s Hims & Hers Health HIMS Stock Holding History

VanEck Associates’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222K	Sell	6,415 -290,609	-98%	-$7.8M	﹤0.01%	1292
2026 Q1	$6.17M	Buy	297,024 +65,851	+28%	+$1.56M	﹤0.01%	747
2025 Q4	$7.51M	Buy	231,173 +25,754	+13%	+$1.1M	0.01%	650
2025 Q3	$11.7M	Buy	205,419 +18,991	+10%	+$973K	0.01%	491
2025 Q2	$9.29M	Buy	186,428 +119,075	+177%	+$5.38M	0.01%	509
2025 Q1	$1.99M	Buy	67,353 +63,791	+1,791%	+$2.37M	﹤0.01%	956
2024 Q4	$86K	Sell	3,562 -274	-7%	-$6.79K	﹤0.01%	1278
2024 Q3	$82K	Sell	3,836 -1,648	-30%	-$29.5K	﹤0.01%	1259
2024 Q2	$111K	Buy	+5,484	New	+$91.2K	﹤0.01%	1244

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VanEck Associates's HIMS Position: Q2 2026 in Review

VanEck Associates reduced its Hims & Hers Health (HIMS) stake by 98% in Q2 2026, selling an estimated $7.8M and leaving 6,415 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #1292.

VanEck Associates first reported a position in HIMS in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.7M in Q3 2025. 507 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

VanEck Associates held 6,415 shares of Hims & Hers Health worth $222K as of Q2 2026.
VanEck Associates sold 290,609 Hims & Hers Health shares in Q2 2026, an estimated $7.8M.
Hims & Hers Health made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1292 holding.
VanEck Associates first reported a position in Hims & Hers Health in Q2 2024 and has held it in 9 quarters since.
VanEck Associates's Hims & Hers Health position peaked at $11.7M in Q3 2025.
507 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.